US Stock MarketDetailed Quotes
VIVE Viveve Medical
- 0.000400
- +0.000300+300.00%
15min DelayClose Nov 22 16:00 ET
4.29KMarket Cap0.00P/E (TTM)
0.000400High0.000001Low4.95KVolume0.000100Open0.000100Pre Close0.50Turnover0.05%Turnover Ratio0.00P/E (Static)10.72MShares0.11070052wk High0.00P/B4.29KFloat Cap0.00000152wk Low--Dividend TTM10.72MShs Float22099995.580000Historical High--Div YieldTTM399.00%Amplitude0.000001Historical Low0.000000Avg Price1Lot Size
Viveve Medical Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -25.80%-3.35M | -22.30%-4.57M | -56.38%-5.09M | 15.47%-12.88M | -40.43%-3.23M | 3.06%-2.66M | 16.12%-3.74M | 43.29%-3.25M | 51.23%-15.23M | 57.24%-2.3M |
| Net income from continuing operations | 15.06%-4.98M | -43.19%-5.8M | -1.64%-5.89M | -0.51%-22.03M | -33.08%-6.33M | -56.84%-5.86M | 43.08%-4.05M | 8.23%-5.79M | 48.47%-21.92M | 67.91%-4.76M |
| Operating gains losses | -98.44%1K | 112.53%140K | -99.66%1K | -146.93%-872K | -2,016.67%-115K | 357.14%64K | ---1.12M | --296K | 1,620.37%1.86M | -60.00%6K |
| Depreciation and amortization | -29.27%174K | -42.15%188K | -37.80%204K | -12.18%1.14M | -27.05%240K | -21.15%246K | -0.91%325K | 0.00%328K | 9.73%1.3M | -8.36%329K |
| Other non cash items | 12.90%175K | -36.99%46K | 29.82%283K | -6.10%862K | 106.97%416K | -18.85%155K | -66.36%73K | -29.45%218K | -89.70%918K | -97.21%201K |
| Change In working capital | -75.72%395K | -453.15%-505K | -178.93%-648K | 928.17%4.12M | 31.47%1.53M | 687.36%1.63M | 126.83%143K | 196.93%821K | 78.73%-497K | 259.13%1.16M |
| -Change in receivables | -143.11%-72K | 24.48%-290K | -88.89%41K | -72.49%96K | 72.00%-56K | -24.77%167K | -458.88%-384K | 67.73%369K | -88.75%349K | -143.01%-200K |
| -Change in inventory | -81.51%105K | -90.63%43K | -108.33%-33K | 62.28%2.21M | -30.43%784K | 24.84%568K | 185.79%459K | 26.52%396K | 227.10%1.36M | 235.13%1.13M |
| -Change in prepaid assets | 294.74%185K | -125.45%-14K | -233.60%-338K | -115.89%-24K | 55.45%-237K | -160.51%-95K | -80.57%55K | 4.12%253K | 36.04%151K | -188.08%-532K |
| -Change in payables and accrued expense | -37.33%638K | -408.24%-432K | 196.01%433K | 136.58%1.15M | -1.76%670K | 175.52%1.02M | 82.40%-85K | 77.45%-451K | 19.71%-3.15M | -19.48%682K |
| -Change in other current assets | -220.14%-461K | 2,188.89%188K | -25.33%112K | -30.59%320K | 1,800.00%323K | -633.33%-144K | ---9K | -64.03%150K | 1,052.50%461K | --17K |
| -Change in other current liabilities | --0 | --0 | -929.81%-863K | 10.27%365K | -37.88%41K | -46.19%113K | 12.63%107K | 360.00%104K | 155.26%331K | 108.70%66K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -25.80%-3.35M | -22.30%-4.57M | -56.38%-5.09M | 15.47%-12.88M | -40.43%-3.23M | 3.06%-2.66M | 16.12%-3.74M | 43.29%-3.25M | 51.23%-15.23M | 57.24%-2.3M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -129.76%-193K | -942.86%-59K | 42.35%-49K | 41.61%-456K | 22.22%-294K | 24.32%-84K | 105.34%7K | 47.20%-85K | 28.15%-781K | -58.16%-378K |
| Net PPE purchase and sale | -129.76%-193K | -942.86%-59K | 42.35%-49K | 41.61%-456K | 22.22%-294K | 24.32%-84K | 105.34%7K | 47.20%-85K | 28.15%-781K | -58.16%-378K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -129.76%-193K | -942.86%-59K | 42.35%-49K | 41.61%-456K | 22.22%-294K | 24.32%-84K | 105.34%7K | 47.20%-85K | 28.15%-781K | -58.16%-378K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -9.52%19K | -98.07%13K | -99.92%19K | 181.40%25.97M | 1,900.00%18K | -99.41%21K | -83.35%673K | 1,448.80%25.26M | -42.70%9.23M | -100.01%-1K |
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --1.34M | --0 |
| Net common stock issuance | --0 | --0 | --0 | 7,473.61%25.83M | --0 | --0 | 106.45%704K | --25.12M | -97.90%341K | --0 |
| Proceeds from stock option exercised by employees | -9.52%19K | --13K | -89.39%19K | -97.42%217K | --17K | -99.42%21K | --0 | -89.22%179K | 14,912.50%8.41M | --0 |
| Net other financing activities | ---- | ---- | ---- | 91.87%-70K | 200.00%1K | --0 | 96.03%-31K | -33.33%-40K | -287.84%-861K | 99.15%-1K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -9.52%19K | -98.07%13K | -99.92%19K | 181.40%25.97M | 1,900.00%18K | -99.41%21K | -83.35%673K | 1,448.80%25.26M | -42.70%9.23M | -100.01%-1K |
| Net cash flow | ||||||||||
| Beginning cash position | -62.86%9.43M | -50.63%14.05M | 193.76%19.16M | -50.98%6.52M | 146.36%22.67M | 198.72%25.39M | 214.60%28.45M | -50.98%6.52M | -54.92%13.31M | 1.25%9.2M |
| Current changes in cash | -29.27%-3.52M | -51.03%-4.61M | -123.34%-5.12M | 286.28%12.64M | -30.86%-3.5M | -489.43%-2.73M | -463.65%-3.06M | 613.90%21.92M | 58.16%-6.79M | -163.41%-2.68M |
| End cash Position | -73.94%5.91M | -62.86%9.43M | -50.63%14.05M | 193.76%19.16M | 193.76%19.16M | 146.36%22.67M | 198.72%25.39M | 214.60%28.45M | -50.98%6.52M | -50.98%6.52M |
| Free cash flow | -28.98%-3.54M | -24.11%-4.63M | -53.86%-5.14M | 16.74%-13.33M | -31.58%-3.52M | 3.88%-2.75M | 18.67%-3.73M | 43.39%-3.34M | 50.45%-16.02M | 52.32%-2.68M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
